You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

COREG Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Coreg, and when can generic versions of Coreg launch?

Coreg is a drug marketed by Woodward and is included in two NDAs. There is one patent protecting this drug.

The generic ingredient in COREG is carvedilol phosphate. There are thirty-seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the carvedilol phosphate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Coreg

A generic version of COREG was approved as carvedilol phosphate by SUN PHARM INDUSTRIES on October 25th, 2017.

  Try a Trial

US Patents and Regulatory Information for COREG

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Woodward COREG carvedilol TABLET;ORAL 020297-004 May 29, 1997 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Woodward COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-003 Oct 20, 2006 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Woodward COREG carvedilol TABLET;ORAL 020297-001 Sep 14, 1995 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Woodward COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-004 Oct 20, 2006 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Woodward COREG carvedilol TABLET;ORAL 020297-003 Sep 14, 1995 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Woodward COREG carvedilol TABLET;ORAL 020297-002 Sep 14, 1995 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Woodward COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-002 Oct 20, 2006 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for COREG

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Woodward COREG carvedilol TABLET;ORAL 020297-004 May 29, 1997 ⤷  Try a Trial ⤷  Try a Trial
Woodward COREG carvedilol TABLET;ORAL 020297-004 May 29, 1997 ⤷  Try a Trial ⤷  Try a Trial
Woodward COREG carvedilol TABLET;ORAL 020297-003 Sep 14, 1995 ⤷  Try a Trial ⤷  Try a Trial
Woodward COREG carvedilol TABLET;ORAL 020297-004 May 29, 1997 ⤷  Try a Trial ⤷  Try a Trial
Woodward COREG carvedilol TABLET;ORAL 020297-002 Sep 14, 1995 ⤷  Try a Trial ⤷  Try a Trial
Woodward COREG carvedilol TABLET;ORAL 020297-002 Sep 14, 1995 ⤷  Try a Trial ⤷  Try a Trial
Woodward COREG carvedilol TABLET;ORAL 020297-003 Sep 14, 1995 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for COREG

See the table below for patents covering COREG around the world.

Country Patent Number Title Estimated Expiration
Czechoslovakia 227047 METHOD OF PREPARING CARBAZOL-4-YL OXYPROPANOLAMINE DERIVATIVES ⤷  Try a Trial
Australia 4718196 ⤷  Try a Trial
Norway 973667 ⤷  Try a Trial
Czech Republic 292002 Léčivo pro snížení úmrtnosti způsobené městnavým selháním srdce u savců (Medicament for decreasing mortality resulting from congestive heart failure in mammals) ⤷  Try a Trial
Finland 973255 ⤷  Try a Trial
Greece 3030966 ⤷  Try a Trial
Austria 375639 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.